Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 988-994, March 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bachmann, F.
Right arrow Articles by Burger, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bachmann, F.
Right arrow Articles by Burger, M. M.

Cloning of a Novel Protein Overexpressed in Human Mammary Carcinoma

Felix Bachmann1, Rahel Bänziger1 and Max M. Burger2

Friedrich Miescher-Institute, P. O. Box 2543, CH-4002 Basel, Switzerland

A novel Mr 150,000 protein (p150), which was found to be preferentially expressed in virally and oncogene transformed mouse cells, was partially purified, and the cDNA was cloned. p150 is the largest member of a putative protein family, the molecular function of which is as yet unknown. Its pattern of expression correlates well not only with transformation but also with the dedifferentiated state of several mouse cell lines and cells. Furthermore, human breast carcinoma specimens and normal tissue from the same breast were screened for the presence of the p150 antigen. In all carcinoma samples, Western blotting revealed higher p150 expression levels than that in control tissue from the same patient. Immunohistochemical analyses of the same specimens displayed specific staining of the carcinoma cells.

1 Contributed equally to this work.

2 To whom requests for reprints should be addressed.

Received 6/ 6/96. Accepted 1/17/97.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Zhang, X. Pan, and J. W. B. Hershey
Individual Overexpression of Five Subunits of Human Translation Initiation Factor eIF3 Promotes Malignant Transformation of Immortal Fibroblast Cells
J. Biol. Chem., February 23, 2007; 282(8): 5790 - 5800.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Z. Dong and J.-T. Zhang
EIF3 p170, a Mediator of Mimosine Effect on Protein Synthesis and Cell Cycle Progression
Mol. Biol. Cell, September 1, 2003; 14(9): 3942 - 3951.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Singhal, R. Wiewrodt, L. D. Malden, K. M. Amin, K. Matzie, J. Friedberg, J. C. Kucharczuk, L. A. Litzky, S. W. Johnson, L. R. Kaiser, et al.
Gene Expression Profiling of Malignant Mesothelioma
Clin. Cancer Res., August 1, 2003; 9(8): 3080 - 3097.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.